The principle of homeostasis in the hypothalamus-pituitary-adrenal system: New insight from positive feedback

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 293, Issue 1, 2007, Pages

  Peters, A ^a   Conrad, M ^a   Hubold, C ^a   Schweiger, U ^a   Fischer, B ^a   Fehm, H L ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Glucocorticoid receptor; Mathematical modeling; Mineralocorticoid receptor; Obesity

Indexed keywords

GLUCOCORTICOID RECEPTOR; HYDROCORTISONE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG USE; ENDOCRINE DISEASE; FEEDBACK SYSTEM; FEMALE; GENDER; HOMEOSTASIS; HORMONAL REGULATION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MATHEMATICAL ANALYSIS; OBESITY; PRIORITY JOURNAL; REGULATORY MECHANISM;

ADDISON DISEASE; ADRENALECTOMY; ADRENOCORTICOTROPIC HORMONE; ADULT; CORTICOTROPIN-RELEASING HORMONE; DATA INTERPRETATION, STATISTICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEEDBACK, BIOCHEMICAL; FEMALE; HOMEOSTASIS; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; OBESITY; PITUITARY ACTH HYPERSECRETION; PITUITARY-ADRENAL SYSTEM; RECEPTORS, MINERALOCORTICOID;

EID: 34447632794     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00907.2006     Document Type: Article

References (101)

1. Acheson A, Conover JC, Fandl JP, DeChiara TM, Russell M, Thadani A, Squinto SP, Yancopoulos GD, Lindsay RM. A BDNF autocrine loop in adult sensory neurons prevents cell death. Nature 374: 450-453, 1995.
2. Angeli D, Ferrell JE Jr., Sontag ED. Detection of multistability, bifurcations, and hysteresis in a large class of biological positive-feedback systems. Proc Natl Acad Sci USA 101: 1822-1827, 2004.
3. Arvat E, Maccagno B, Giordano R, Pellegrino M, Broglio F, Gianotti L, Maccario M, Camanni F, Ghigo E. Mineralocorticoid receptor blockade by canrenoate increases both spontaneous and stimulated adrenal function in humans. J Clin Endocrinol Metab 86: 3176-3181, 2001.
4. Avital A, Segal M, Richter-Levin G. Contrasting roles of corticosteroid receptors in hippocampal plasticity. J Neurosci 26: 9130-9134, 2006.
5. Bahrenberg G, Behrmann I, Barthel A, Hekerman P, Heinrich PC, Joost HG, Becker W. Identification of the critical sequence elements in the cytoplasmic domain of leptin receptor isoforms required for Janus kinase/signal transducer and activator of transcription activation by receptor heterodimers. Mol Endocrinol 16: 859-872, 2002.
6. Barker PA. p75NTR: A study in contrasts. Cell Death Differ 5: 346-356, 1998.
7. Beato M, Herrlich P, Schutz G. Steroid hormone receptors: many actors in search of a plot. Cell 83: 851-857, 1995.
8. Bell ME, Bhatnagar S, Liang J, Soriano L, Nagy TR, Dallman MF. Voluntary sucrose ingestion, like corticosterone replacement, prevents the metabolic deficits of adrenalectomy. J Neuroendocrinol 12: 461-470, 2000.
9. Bellen A, Zennaro M. Numerical Methods for Delay Differential Equations. New York: Oxford University, 2003.
10. Berger S, Wolfer DP, Selbach O, Alter H, Erdmann G, Reichardt HM, Chepkova AN, Welzl H, Haas HL, Lipp HP, Schutz G. Loss of the limbic mineralocorticoid receptor impairs behavioral plasticity. Proc Natl Acad Sci USA 103: 195-200, 2006.
11. Bibel M, Hoppe E, Barde YA. Biochemical and functional interactions between the neurotrophin receptors trk and p75NTR. EMBO J 18: 616-622, 1999.
12. Born J, DeKloet ER, Wenz H, Kern W, Fehm HL. Sleep-influence of mr/gr- corticosteronreceptor. Am J Physiol Endocrinol Metab 260: E183-E188, 1991.
13. Brandman O, Ferrell JE, Li R, Meyer T. Interlinked fast and slow positive feedback loops drive reliable cell decisions. Science 310: 496-498, 2005.
14. Bridgham JT, Carroll SM, Thornton JW. Evolution of hormone-receptor complexity by molecular exploitation. Science 312: 97-101, 2006.
15. Buccafusco JJ, Brezenoff HE. Opposing influences on behavior mediated by muscarinic and nicotinic receptors in the rat posterior hypothalamic nucleus. Psychopharmacology (Berl) 67: 249-254, 1980.
16. Calabrese EJ. Adrenergic receptors: biphasic dose responses. Crit Rev Toxicol 31: 523-538, 2001.
17. Calabrese EJ, Baldwin LA. Peptides and hormesis. Crit Rev Toxicol 33: 355-405, 2003.
18. Cannon WB. The Wisdom of the Body. New York: W. W. Norton, 1932.
19. Chao MV, Hempstead BL. p75 and Trk: a two-receptor system. Trends Neurosci 18: 321-326, 1995.
20. Chen SC, Kochan JP, Campfield LA, Burn P, Smeyne RJ. Splice variants of the OB receptor gene are differentially expressed in brain and peripheral tissues of mice. J Recept Signal Transduct Res 19: 245-266, 1999.
21. Chow YS, Teicher H. Probability Theory: Independence Interchangeability, Martingales. New York: Springer, 1997.
22. Conrad M, Hubold C, Fischer B, Peters A. The selfish brain: a new model of the LHPA system. Exp Clin Endocrinol Diabetes 112: 481-482. 2004.
23. Croce A, Astier H, Recasens M, Vignes M. Opposite effects of alpha 1- and beta-adrenoceptor stimulation on both glutamate- and gamma-aminobutyric acid-mediated spontaneous transmission in cultured rat hippocampal neurons. J Neurosci Res 71: 516-525, 2003.
24. Crochemore C, Lu J, Wu Y, Liposits Z, Sousa N, Holsboer F, Almeida OF. Direct targeting of hippocampal neurons for apoptosis by glucocorticoids is reversible by mineralocorticoid receptor activation. Mol Psychiatry 10: 790-798, 2005.
25. Crochemore C, Lu J, Wu Y, Liposits Z, Sousa N, Holsboer F, Almeida OF. Direct targeting of hippocampal neurons for apoptosis by glucocorticoids is reversible by mineralocorticoid receptor activation. Mol Psychiatry 10: 790-798, 2005.
26. Dallman MF. Fast glucocorticoid actions on brain: Back to the future. Front Neuroendocrinol 26: 103-108, 2005.
27. Dallman MF, Pecoraro N, Akana SF, la Fleur SE, Gomez F, Houshyar H, Bell ME, Bhatnagar S, Laugero KD, Manalo S. Chronic stress and obesity: a new view of "comfort food". Proc Natl Acad Sci USA 100: 11696-11701, 2003.
28. de Kloet ER, Vreugdenhil E, Oitzl MS, Joels M. Brain corticosteroid receptor balance in health and disease. Endocr Rev 19: 269-301, 1998.
29. De Meyts P, Wallach B, Christoffersen CT, Urso B, Gronskov K, Latus LJ, Yakushiji F, Ilondo MM, Shymko RM. The insulin-like growth factor-I receptor. Structure, ligand-binding mechanism and signal transduction. Horm Res 42: 152-169, 1994.
30. Derendorf H, Mollmann H, Barth J, Mollmann C, Tunn S, Krieg M. Pharmacokinetics and oral bioavailability of hydrocortisone. J Clin Pharmacol 31: 473-476, 1991.
31. Deuschle M, Weber B, Colla M, Muller M, Kniest A, Heuser I. Mineralocorticoid receptor also modulates basal activity of hypothalamus- pituitary-adrenocortical system in humans. Neuroendocrinology 68: 355-360, 1998.
32. Di S, Malcher-Lopes R, Halmos KC, Tasker JG. Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism. J Neurosci 23: 4850-4857, 2003.
33. Distefano JJ, III. A retrospective on the modeling methodology forum. The review process for modeling papers: a revisionist's experiences and perspectives. Am J Physiol Endocrinol Metab 267: E485-E488, 1994.
34. DiStefano JJ, Stubberud AR, Williams IJ. Theory and Problems of Feedback and Control Systems. New York: McGraw-Hill, 1997.
35. Dodt C, Kern W, Fehm HL, Born J. Antimineralocorticoid canrenoate enhances secretory activity of the hypothalamus-pituitary-adrenocortical (HPA) axis in humans. Neuroendocrinology 58: 570-574, 1993.
36. During MJ, Leone P, Davis KE, Kerr D, Sherwin RS. Glucose modulates rat substantia nigra GABA release in vivo via ATP-sensitive potassium channels. J Clin Invest 95: 2403-2408, 1995.
37. Fehm HL, Voigt KH, Kummer G, Lang R, Pfeiffer EF. Differential and integral corticosteroid feedback effects on ACTH secretion in hypoadrenocorticism. J Clin Invest 63: 247-253, 1979.
38. Fehm HL, Voigt KH, Lang RE, Beinert KE, Kummer GW, Pfeiffer EF. Paradoxical ACTH response to glucocorticoids in Cushing's disease. N Engl J Med 297: 904-907, 1977.
39. Fletcher R. Practical Methods of Optimization. New York: Wiley, 1999.
40. Fukuda N, Kubo A, Izumi Y, Soma M, Kanmatsuse K. Characteristics and expression of transforming growth factor-beta receptor subtypes on vascular smooth muscle cells from spontaneously hypertensive rats. J Hypertens 13: 831-837, 1995.
41. Ginsberg AB, Campeau S, Day HE, Spencer RL. Acute glucocorticoid pretreatment suppresses stress-induced hypothalamic-pituitary-adrenal axis hormone secretion and expression of corticotropin-releasing hormone hnRNA but does not affect c-fos mRNA or fos protein expression in the paraventricular nucleus of the hypothalamus. J Neuroendocrinol 15: 1075-1083, 2003.
42. Ginsberg AB, Frank MG, Francis AB, Rubin BA, O'Connor KA, Spencer RL. Specific and time-dependent effects of glucocorticoid receptor agonist RU28362 on stress-induced pro-opiomelanocortin hnRNA, c-fos mRNA and zif268 mRNA in the pituitary. J Neuroendocrinol 18: 129-138, 2006.
43. Goodman LV, Majack RA. Vascular smooth muscle cells express distinct transforming growth factor-beta receptor phenotypes as a function of cell density in culture. J Biol Chem 264: 5241-5244, 1989.
44. Goumans MJ, Valdimarsdottir G, Itoh S, Rosendahl A, Sideras P, Ten Dijke P. Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. EMBO J 21: 1743-1753, 2002.
45. Gudmundsson A, Carnes M. Pulsatile adrenocorticotropic hormone: an overview. Biol Psychiatry 41: 342-365, 1997.
46. Hairer E, Nørsett SP, Wanner G. Solving Ordinary Differential Equations I. New York: Springer Verlag, 1993.
47. Heuser I, Deuschle M, Weber B, Stalla GK, Holsboer F. Increased activity of the hypothalamus-pituitary-adrenal system after treatment with the mineralocorticoid receptor antagonist spironolactone. Psychoneuroendocrinology 25: 513-518, 2000.
48. Hinz B, Hirschelmann R. Rapid non-genomic feedback effects of glucocorticoids on CRF-induced ACTH secretion in rats. Pharm Res 17: 1273-1277, 2000.
49. + channels. Neuron 16: 1011-1017, 1996.
50. Joels M, Hesen W, de Kloet ER. Long-term control of neuronal excitability by corticosteroid hormones. J Steroid Biochem Mol Biol 53: 315-323, 1995.
51. Karst H, Berger S, Turiault M, Tronche F, Schutz G, Joels M. Mineralocorticoid receptors are indispensable for nongenomic modulation of hippocampal glutamate transmission by corticosterone. Proc Natl Acad Sci USA 102: 19204-19207, 2005.
52. Kim JJ, Diamond DM. The stressed hippocampus, synaptic plasticity and lost memories. Nat Rev Neurosci 3: 453-462, 2002.
53. Korz V, Frey JU. Stress-related modulation of hippocampal long-term potentiation in rats: Involvement of adrenal steroid receptors. J Neurosci 23: 7281-7287, 2003.
54. Krozowski ZS, Funder JW. Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity. Proc Natl Acad Sci USA 80: 6056-6060, 1983.
55. Kulkarni RN, Bruning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR. Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 96: 329-339, 1999.
56. Laugero KD, Bell ME, Bhatnagar S, Soriano L, Dallman MF. Sucrose ingestion normalizes central expression of corticotropin-releasing-factor messenger ribonucleic acid and energy balance in adrenalectomized rats: a glucocorticoid-metabolic-brain axis? Endocrinology 142: 2796-2804, 2001.
57. Laugero KD, Gomez F, Manalo S, Dallman MF. Corticosterone infused intracerebroventricularly inhibits energy storage and stimulates the hypothalamo-pituitary axis in adrenalectomized rats drinking sucrose. Endocrinology 143: 4552-4562, 2002.
58. Lavoie C, Mercier JF, Salahpour A, Umapathy D, Breit A, Villeneuve LR, Zhu WZ, Xiao RP, Lakatta EG, Bouvier M, Hebert TE. Beta 1/beta 2-adrenergic receptor heterodimerization regulates beta 2-adrenergic receptor internalization and ERK signaling efficacy. J Biol Chem 277: 35402-35410, 2002.
59. Lee AV, Gooch JL, Oesterreich S, Guler RL, Yee D. Insulin-like growth factor I-induced degradation of insulin receptor substrate 1 is mediated by the 26S proteasome and blocked by phosphatidylinositol 3'-kinase inhibition. Mol Cell Biol 20: 1489-1496, 2000.
60. Liang SD, Vizi ES. Positive feedback modulation of acetylcholine release from isolated rat superior cervical ganglion. J Pharmacol Exp Ther 280: 650-655, 1997.
61. Liu W, Wang J, Sauter NK, Pearce D. Steroid receptor heterodimerization demonstrated in vitro and in vivo. Proc Natl Acad Sci USA 92: 12480-12484, 1995.
62. Liu X, Sood S, Liu H, Horner RL. Opposing muscarinic and nicotinic modulation of hypoglossal motor output to genioglossus muscle in rats in vivo. J Physiol 565: 965-980, 2005.
63. Loose DS, Do YS, Chen TL, Feldman D. Demonstration of glucocorticoid receptors in the adrenal cortex: evidence for a direct dexamethasone suppressive effect on the rat adrenal gland. Endocrinology 107: 137-146, 1980.
64. 2+ ions in their function and desensitization. Neurochem Int 34: 319-328, 1999.
65. Marchi M, Raiteri M. Nicotinic autoreceptors mediating enhancement of acetylcholine release become operative in conditions of "impaired" cholinergic presynaptic function. J Neurochem 67: 1974-1981, 1996.
66. Margetic S, Gazzola C, Pegg GG, Hill RA. Characterization of leptin binding in bovine kidney membranes. Domest Anim Endocrinol 23: 411-424, 2002.
67. McEwen BS, Weiss JM, Schwartz LS. Selective retention of corticosterone by limbic structures in rat brain. Nature 220: 911-912, 1968.
68. Molinoff PB. Alpha- and beta-adrenergic receptor subtypes properties, distribution and regulation. Drugs 28 Suppl 2: 1-15, 1984.
69. O'Donnell D, Francis D, Weaver S, Meaney MJ. Effects of adrenalectomy and corticosterone replacement on glucocorticoid receptor levels in rat brain tissue: a comparison between Western blotting and receptor binding assays. Brain Res 687: 133-142, 1995.
70. O'Rourke L, Shepherd PR. Biphasic regulation of extracellular-signal-regulated protein kinase by leptin in macrophages: role in regulating STAT3 Ser727 phosphorylation and DNA binding. Biochem J 364: 875-879, 2002.
71. Osman R, Keitz SA, Goldfarb J, Maayani S. Kinetics of response and drug action. Neuropsychopharmacology 3: 417-425, 1990.
72. Ou XM, Storring JM, Kushwaha N, Albert PR. Heterodimerization of mineralocorticoid and glucocorticoid receptors at a novel negative response element of the 5-HT1A receptor gene. J Biol Chem 276: 14299-14307, 2001.
73. Pace TWW, Spencer RL. Disruption of mineralocorticoid receptor function increases corticosterone responding to a mild, but not moderate, psychological stressor. Am J Physiol Endocrinol Metab 288: E1082-E1088, 2005.
74. Patel PD, Lopez JF, Lyons DM, Burke S, Wallace M, Schatzberg AF. Glucocorticoid and mineralocorticoid receptor mRNA expression in squirrel monkey brain. J Psychiatr Res 34: 383-392, 2000.
75. Paust HJ, Loeper S, Else T, Bamberger AM, Papadopoulos G, Pankoke D, Saeger W, Bamberger CM. Expression of the glucocorticoid receptor in the human adrenal cortex. Exp Clin Endocrinol Diabetes 114: 6-10, 2006.
76. Pavlides C, McEwen BS. Effects of mineralocorticoid and glucocorticoid receptors on long-term potentiation in the CA3 hippocampal field. Brain Res 851: 204-214, 1999.
77. Pavlides C, Ogawa S, Kimura A, McEwen BS. Role of adrenal steroid mineralocorticoid and glucocorticoid receptors in long-term potentiation in the CA1 field of hippocampal slices. Brain Res 738: 229-235, 1996.
78. Peters A, Pellerin L, Dallman MF, Oltmanns KM, Schweiger U, Born J, Fehm HL. Causes of obesity: looking beyond the hypothalamus. Prog Neurobiol 81: 61-88, 2007.
79. Peters A, Schweiger U, Pellerin L, Hubold C, Oltmanns KM, Conrad M, Schultes B, Born J, Fehm HL. The selfish brain: competition for energy resources. Neurosci Biobehav Rev 28: 143-180, 2004.
80. Raiteri M, Marchi M, Maura G, Bonanno G. Presynaptic regulation of acetylcholine release in the CNS. Cell Biol Int Rep 13: 1109-1118, 1989.
81. Ratka A, Sutanto W, Bloemers M, de Kloet ER. On the role of brain mineralocorticoid (type I) and glucocorticoid (type II) receptors in neuroendocrine regulation. Neuroendocrinology 50: 117-123, 1989.
82. Reul JM, de Kloet ER. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 117: 2505-2511, 1985.
83. Schaffer L. A model for insulin binding to the insulin receptor. Eur J Biochem 221: 1127-1132, 1994.
84. Song DK, Ashcroft FM. ATP modulation of ATP-sensitive potassium channel ATP sensitivity varies with the type of SUR subunit. J Biol Chem 276: 7143-7149, 2001.
85. Sousa N, Almeida OF. Corticosteroids: sculptors of the hippocampal formation. Rev Neurosci 13: 59-84, 2002.
86. Steinkamp M, Li T, Fuellgraf H, Moser A. K(ATP)-dependent neurotransmitter release in the neuronal network of the rat caudate nucleus. Neurochem Int 50: 159-163, 2007.
87. Tarantola A. Inverse Problem Theory and Methods for Model Parameter Estimation. siam. Philadelphia: Society for Industrial and Applied Mathematics, 2005.
88. Trapp T, Holsboer F. Heterodimerization between mineralocorticoid and glucocorticoid receptors increases the functional diversity of corticosteroid action. Trends Pharmacol Sci 17: 145-149, 1996.
89. van Haarst AD, Oitzl MS, de Kloet ER. Facilitation of feedback inhibition through blockade of glucocorticoid receptors in the hippocampus. Neurochem Res 22: 1323-1328, 1997.
90. Van Schravendijk CF, Heylen L, Van den Brande JL, Pipeleers DG. Direct effect of insulin and insulin-like growth factor-I on the secretory activity of rat pancreatic beta cells. Diabetologia 33: 649-653, 1990.
91. Veldhuis JD, Iranmanesh A, Naftolowitz D, Tatham N, Cassidy F, Carroll BJ. Corticotropin secretory dynamics in humans under low glucocorticoid feedback. J Clin Endocrinol Metab 86: 5554-5563, 2001.
92. Vellucci SV, Parrott RF, Mimmack ML. Chronic dexamethasone- treatment alters mineralocorticoid receptor, truncated trkB and selected glutamate receptor subunit mRNA expression in the porcine hippocampus. Neuropeptides 36: 291-298, 2002.
93. Venero C, Borrell J. Rapid glucocorticoid effects on excitatory amino acid levels in the hippocampus: a microdialysis study in freely moving rats. Eur J Neurosci 11: 2465-2473, 1999.
94. Vesa J, Kruttgen A, Shooter EM. p75 reduces TrkB tyrosine autophosphorylation in response to brain-derived neurotrophic factor and neurotrophin 4/5. J Biol Chem 275: 24414-24420, 2000.
95. Wagner U, Degirmenci M, Drosopoulos S, Perras B, Born J. Effects of cortisol suppression on sleep-associated consolidation of neutral and emotional memory. Biol Psychiatry 58: 885-893, 2005.
96. Wellhoener P, Born J, Fehm HL, Dodt C. Elevated resting and exercise-induced cortisol levels after mineralocorticoid receptor blockade with canrenoate in healthy humans. J Clin Endocrinol Metab 89: 5048-5052, 2004.
97. Wilkinson CW, Peskind ER, Raskind MA. Decreased hypothalamic-pituitary-adrenal axis sensitivity to cortisol feedback inhibition in human aging. Neuroendocrinology 65: 79-90, 1997.
98. Woo NH, Teng HK, Siao CJ, Chiaruttini C, Pang PT, Milner TA, Hempstead BL, Lu B. Activation of p75NTR by proBDNF facilitates hippocampal long-term depression. Nat Neurosci 8: 1069-1077, 2005.
99. Young EA, Lopez JF, Murphy Weinberg V, Watson SJ, Akil H. The role of mineralocorticoid receptors in hypothalamic- pituitary-adrenal axis regulation in humans. J Clin Endocrinol Metab 83: 3339-3345, 1998.
100. Zagrebelsky M, Holz A, Dechant G, Barde YA, Bonhoeffer T, Korte M. The p75 neurotrophin receptor negatively modulates dendrite complexity and spine density in hippocampal neurons. J Neurosci 25: 9989-9999, 2005.
101. Zhao AZ, Zhao H, Teague J, Fujimoto W, Beavo JA. Attenuation of insulin secretion by insulin-like growth factor 1 is mediated through activation of phosphodiesterase 3B. Proc Natl Acad Sci USA 94: 3223-3228, 1997.